MAASTRICHT, the Netherlands—Inclisiran, a small, interfering RNA (siRNA) that targets the synthesis of PCSK9 in the liver, can be safely given to patients with and without impaired renal function, as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback